FindTrial
Sign In

A medical records based analysis of the Incidence and Risk Factors of Ventilator-associated Pneumonia in ARDS Patients with Novel Coronavirus Pneumonia (COVID-19)

Analysis of the Incidence and Risk Factors of Ventilator-associated Pneumonia in ARDS Patients with Novel Coronavirus Pneumonia (COVID-19)

Status
Unknown
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2000030753
Enrollment
Unknown
Registered
2020-03-13
Start date
2020-02-01
Completion date
Unknown
Last updated
2020-03-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Novel Coronavirus Pneumonia (COVID-19)

Interventions

case series:no

Sponsors

Shandong Provincial Chest hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
14 Years to 90 Years

Inclusion criteria

Inclusion criteria: 1. Patients who were diagnosed as COVID-19 by nucleic acid test; 2. ARDS patients according to the Berlin definition; 3. Patients in ICU met the VAP criteria and were not associated with other site infection.

Exclusion criteria

Exclusion criteria: 1. With other parts of the infection occurred within 7 days after discontinuation of antibiotic therapy, including urinary tract infections, bloodstream infections, biliary tract infections, central nervous system infections, and so on; 2. The drainage tube of important organs can not be extracted within 14 days; 3. Patients or relatives request to suspend the trial.

Design outcomes

Primary

MeasureTime frame
ICU hospitalization days;The recurrence rate of infection;—

Secondary

MeasureTime frame
PCT;Blood Routine;—

Countries

China

Contacts

Public ContactFenglin Liu

Shandong Provincial Chest hospital

xkyylfl@163.com+86 13953116564

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026